Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
As more nuanced measures gain acceptance, the rigid BMI cutoffs may evolve into more flexible, multi-factor assessments
Testing for key variants like GIPR rs1800437 can reveal whether your genes predispose you to slower metabolic response, helping your provider adjust your tirzepatide dose or consider alternative compounds like semaglutide or GLP-Squared dual therapy for better results
Adjusting the Treatment Plan If semaglutide is likely causing the discomfort, the doctor may: Keep the current dose longer Lower the dose Pause treatment for a short time In rare cases, stop the drug entirely Changes in treatment should only be made by a healthcare provider
, ( + )
Dual Incretin Hormone Activation Tirzepatide activates both GIP and GLP-1 receptors , mimicking natural incretin hormones released after meals
On-demand Webinar The GLP-1 cost crisis: What can you do
